COMMUNIQUÉS West-GlobeNewswire

BioHemp International, Inc. (OTC: BKIT) Announces Deal to Private Label Water From American Premium Water Corporation (OTC: HIPH)
08/07/2019
New Private Label Water To Be Sold Exclusively On BKIT’s Channels NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating [...]
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
08/07/2019
All Aspects of the Biotest Therapy Business Unit (“BTBU”) Acquisition Are Successfully Completed RAMSEY, N.J. and BOCA RATON, Fla., July 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “ [...]
Dentsply Sirona Announces Appointment of Jorge M. Gomez as Chief Financial Officer
08/07/2019
CHARLOTTE, N.C., July 08, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced the appointment of Jorge M. Gomez as Chief Financial Officer. [...]
Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
08/07/2019
Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer Agreements Include Process Transfer, Process Development and Clinical Manufacturing [...]
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
08/07/2019
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases [...]
eSolutions Names Chris F. Hart Vice President, Product & Strategy
08/07/2019
OVERLAND PARK, Kan., July 08, 2019 (GLOBE NEWSWIRE) -- eSolutions, a leading provider of revenue cycle and workflow management technology, announced today that Chris F. Hart has joined the company as Vice President, [...]
Zogenix Completes Enrollment in Phase 3 Trial of FINTEPLA® in Lennox-Gastaut Syndrome
08/07/2019
EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has completed enrollment for, and randomized [...]
HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0
08/07/2019
TUCSON, Ariz., July 08, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the release of its HTG EdgeSeq [...]
Syneos Health Schedules Second Quarter 2019 Earnings Call for Tuesday, August 6, 2019
08/07/2019
MORRISVILLE, N.C., July 08, 2019 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract [...]
REMINDER - TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
08/07/2019
In this poor prognosis population, SM-88 demonstrated median overall survival (OS) of 6.4 months as of April 25, 2019 Efficacy indicators showed strong correlation with greater overall survival (OS). These indicators [...]
Organogenesis Announces 2019 Sponsorship of American Podiatric Medical Association Educational Programs and Annual Scientific Meeting
08/07/2019
CANTON, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Novastep Announces U.S. Launch and Full Commercialization of PECA® MIS Implant System for Bunion Correction
08/07/2019
Orangeburg, NY, July 08, 2019 (GLOBE NEWSWIRE) -- Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in foot and ankle surgery, today announced the U.S. [...]
Alder BioPharmaceuticals® to Showcase 14 New Data Presentations Demonstrating Eptinezumab’s Migraine Prevention and Quality of Life Impact at American Headache Society Meeting
08/07/2019
Posters highlight eptinezumab’s impact in chronic and episodic migraine clinical trials, including data on migraine-free months and early, sustained reduction in chronic migraine severity BOTHELL, Wash., July 08, 2019 ( [...]
Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR001 for the Treatment of Parkinson’s Disease Patients with a GBA1 Mutation
08/07/2019
Company Plans to Initiate Phase 1/2 Clinical Trial in the Second Half of 2019 NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (Prevail), a biotechnology company developing [...]
Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations
08/07/2019
EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
08/07/2019
Primary endpoint of event free survival (EFS) rate at 180 days of 90.9 percent reported for rivo‑cel in BP-004 European registrational trial Investigational trial results support potential that haploidentical stem cell [...]
Adverum Biotechnologies to Present Data at Upcoming Conferences
08/07/2019
-- OPTIC Phase 1 Data for ADVM-022 in Wet AMD for First Cohort to be Presented at Retina Society Annual Meeting in September 2019 -- MENLO PARK, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. ( [...]
James Green Named President and CEO of Harvard Bioscience
08/07/2019
HOLLISTON, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by its Board of Directors [...]
SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox
08/07/2019
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has been awarded a [...]

Pages